Please provide us with a few details so that we can match you with the right expert in your field.
*Required
Our DMPK experts help steer your project to success with a clear insight into the pharmacokinetics of your therapeutic. The team develop impactful in vivo PK studies before generating and interpreting data that helps you make informed decisions about the next stage of your project.
Our Tier 4 - Scientific Validation is suitable for support of in vitro projects, early development, non-regulated, non-clinical and clinical sample analyses where method validation assessments are required in addition to the offerings included in Tier 3. Studies are managed as separate method development, method validation and sample analysis studies, with the option of Quality Audit (QA) for method validations and sample analyses if selected. Method development studies include pre-validation assessments to ensure methods are suitable to progress to validation. The validation assessments will be based on industry guidelines, with flexibility as to which assessments are included. Typically, stability in matrix will be conducted up to a 1-month timepoint.
Find out how we can help you rapidly evaluate the PK of your therapeutic and have a confidential discussion with our experts about your project needs.